7,129
Views
131
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Lactobacillus fermentum ME-3 – an antimicrobial and antioxidative probiotic

&
Pages 1-27 | Received 14 Oct 2008, Published online: 11 Jul 2009

References

  • Mackie RI. Mutualistic fermentative digestion in the gastrointestinal tract: diversity and evolution. Integ Comp Biol 2002; 42: 319–26
  • McFarland LV. Normal flora: diversity and functions. Microb Ecol Health Dis 2000; 12: 193–218
  • Dubos R, Schaedler RW. Some biological effects of the digestive flora. Am J Med Sci 1962; 244: 265–71
  • Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107–33
  • Savage DC. The normal human microflora composition. The regulatory and protective role of the normal microflora, R Grubb, T Midtvedt, E Norin. N-Stockton Press, New York 1989; 3–18
  • Bhat P, Albert MJ, Rajan D, Ponniah J, Mathan VI, Baker SJ. Bacterial flora of the jejunum: a comparison of luminal aspirate and mucosal biopsy. J Med Microbiol 1980; 13: 247–56
  • Croucher SC, Houston AP, Bayliss CE, Turner RJ. Bacterial populations associated with different regions of the human colon wall. Appl Environ Microbiol 1983; 45: 1025–33
  • Mikelsaar, ME, Tjuri, ME, Valjaots, ME, Lencner, AA. [Anaerobic lumen and mucosal microflora of the gastrointestinal tract.]. Nahrung 1984;28:727–33, (in German).
  • Mikelsaar, M, Turi, M, Lencner, H, Kolts, K, Kirch, R, Lencner, A. Interrelations between mucosal and luminal microflora of gastrointestine. Nahrung 1987;31:449–56, 637–8.
  • Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68: 3401–7
  • Nielsen DS, Moller PL, Rosenfeldt V, Paerregaard A, Michaelsen KF, Jakobsen M. Case study of the distribution of mucosa-associated Bifidobacterium species, Lactobacillus species, and other lactic acid bacteria in the human colon. Appl Environ Microbiol 2003; 69: 7545–8
  • Lepage P, Seksik P, Sutren M, de la Cochetiere MF, Jian R, Marteau P, et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005; 11: 473–80
  • van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen HM, et al. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm Bowel Dis 2005; 11: 865–71
  • Mikelsaar M, Mändar R. Development of individual lactic acid microflora in the human microbial ecosystem. Lactic acid bacteria, S Salminen, A von Wright. Marcel Dekker, New York 1993; 237–93
  • Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998; 64: 3854–9
  • Holdeman LV, Good IJ, Moore WE. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol 1976; 31: 359–75
  • Bochkov, IA, Lizko, NN, Semina, NA, Borunov, NL, Iurko, LP. [Peculiarities of cosmonauts faecal flora.]. Aviakosm Ekolog Med 1998;32:25–8, (in Russian).
  • Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL. Fecal microbial flora in Seventh Day Adventist populations and control subjects. Am J Clin Nutr 1977; 30: 1781–92
  • Bry L, Falk PG, Midtvedt T, Gordon JI. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996; 273: 1380–3
  • Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837–48
  • Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 2008; 105: 2117–22
  • Zoetendal EG, Akkermans AD, Akkermans-van der Vliet VM, De Visser JA, De Vos WM. The host genotype affects the bacterial community in the human gastrointestinal tract. Microb Ecol Health Dis 2001; 13: 129–34
  • Mikelsaar M., Mändar R., Sepp E. Lactic acid microflora in the human microbial ecosystem and its development. Lactic acid bacteria. Marcel Dekker, New York 1998; 279–342
  • Van de Merwe JP, Stegeman JH, Hazenberg MP. The resident faecal flora is determined by genetic characteristics of the host. Implications for Crohn's disease?. Antonie Van Leeuwenhoek 1983; 49: 119–24
  • Apperloo-Renkema HZ, Jagt TG, Tonk RH, van der Waaij D. Healthy individuals possess circulating antibodies against their indigenous faecal microflora as well as against allogenous faecal microflora: an immunomorphometrical study. Epidemiol Infect 1993; 111: 273–85
  • Kimura K, McCartney AL, McConnell MA, Tannock GW. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Appl Environ Microbiol 1997; 63: 3394–8
  • Egert M, De Graaf AA, Smidt H, De Vos WM, Venema K. Beyond diversity: functional microbiomics of the human colon. Trends Microbiol 2006; 14: 86–91
  • McFarland LV. Beneficial microbes: health or hazard?. Eur J Gastroenterol Hepatol 2000; 12: 1069–71
  • O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688–93
  • Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol 2004; 70: 3189–94
  • van der Waaij D, Berghuis JM. Determination of the colonization resistance of the digestive tract of individual mice. J Hyg (Lond) 1974; 72: 379–87
  • Naaber, P, Mikelsaar, M. Interactions between lactobacilli and antibiotic-associated diarrhea, In: AI Laskin, Bennett, JW, Gadd, GM. Advances in applied microbiology. vol 54. New York: Elsevier; 2004. p. 231–60.
  • Bäckhed F, Ley RF, Sonnenberg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915–20
  • Banasaz M, Alam M, Norin E, Midtvedt T. Gender, age and microbial status influence upon intestinal cell kinetics in a compartmentalized manner: an experimental study in germfree and conventional rats. Microb Ecol Health Dis 2000; 12: 208–18
  • Mikelsaar, M . Evaluation of the gastrointestinal microbial ecosystem in health and disease. Dis Med Univ Tartuensis, Tartu, 1992.
  • Sepp E, Naaber P, Voor T, Mikelsaar M, Björkstén B. Development of intestinal microflora during the first month of life in Estonian and Swedish infants. Microb Ecol Health Dis 2000; 12: 22–6
  • Mikelsaar M, Siigur U, Lenzner A. Evaluation of the quantitative composition of fecal microflora. Laboratornoje Delo 1990; 5: 62–6
  • Sepp E, Julge K, Vasar M, Naaber P, Bjorksten B, Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997; 86: 956–61
  • Sepp E, Julge K, Mikelsaar M, Bjorksten B. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children. Clin Exp Allergy 2005; 35: 1141–6
  • Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108: 516–20
  • Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998; 64: 3336–45
  • Zoetendal EG, Vaughan EE, de Vos WM. A microbial world within us. Mol Microbiol 2006; 59: 1639–50
  • Rajilić-Stojanović M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007; 9: 2125–36
  • Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 2005; 71: 4679–89
  • Midtvedt T, Bjorneklett A, Carlstedt-Duke B, Gustafsson BE, Hoverstad T, Lingaas E, et al. The influence of antibiotics upon microflora-associated characteristics in man and mammals. Prog Clin Biol Res 1985; 181: 241–4
  • Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998; 62: 1157–70
  • Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335–76
  • Tamm A, Siigur U, Mikelsaar M, Vija M. Output of bacterial metabolites as a diagnostic means. Nahrung 1987; 31: 485–92
  • Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 2006; 17: 204–10
  • De Vos WM, Bron PA, Kleerebezem M. Post-genomics of lactic acid bacteria and other food-grade bacteria to discover gut functionality. Curr Opin Biotechnol 2004; 15: 86–93
  • Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JL. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 2005; 102: 11070–5
  • Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, et al. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005; 307: 1955–9
  • Lay C, Rigottier-Gois L, Holmstrom K, Rajilic M, Vaughan EE, de Vos WM, et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 2005; 71: 4153–5
  • Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635–8
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027–31
  • ILSI Europe. Scientific concepts of functional foods in Europe: consensus document. Br J Nutr. 1999;81:1S–27S.
  • Strachan DP, Golding J, Anderson HR. Regional variations in wheezing illness in British children: effect of migration during early childhood. J Epidemiol Community Health 1990; 44: 231–6
  • Holt PG., Macaubas C, Prescott SL, Sly PD. Microbial stimulation as an aetiologic factor in atopic disease. Allergy 1999; 54: 12–16
  • Adlerberth, I . The establishment of normal intestinal microflora in the newborn infants. PhD Dissertation, Göteborg, 1996.
  • Bennet R, Eriksson M, Nord CE, Zetterström R. Suppression of aerobic and anaerobic fecal flora in newborns receiving parenteral gentamicin and ampicillin. Acta Paediatr Scand 1982; 71: 559–62
  • Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol 2007; 51: 260–9
  • Sepp E, Voor T, Julge K, Lõivukene K, Björkstén B, Mikelsaar M. Is intestinal microbiota bound up with changing lifestyle?. Modern multidisciplinary applied microbiology: exploiting microbes and their interactions, A Mendez-Vilas. Wiley-VCH Verlag, WeinheimGermany 2006; 708–12
  • Björkstén B, Graninger G, Jacobsson Ekman G. New ideas in asthma and allergy research: creating a multidisciplinary graduate school. J Clin Invest 2003; 112: 816–20
  • Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003; 36: 223–7
  • Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR, Isolauri E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001; 32: 1–7
  • Food Agriculture Organization : Guidelines for the evaluation of probiotics in food. Available at: http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
  • Mercenier A, Lenoir-Wijnkoop I, Sanders ME. Physiological and functional properties of probiotics. Bull Int Dairy Fed 2008; 429: 2–6
  • Rijkers, GT , Watzl, B , Rabot, S , Rafter, J , Antoine, JM , Haller, D , . ILSI Europe Workshop in association with the International Dairy Federation, et al . Guidance for assessing the probiotics beneficial effects: how to fill GAP. 22–24, May, 2008, Montreaux, Switzerland.
  • Reid G, Kim SO, Kohler GA. Selecting, testing and understanding probiotic microorganisms. FEMS Immunol Med Microbiol 2006; 46: 149–57
  • Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 2001; 73: 1124S–1130S
  • Ljungh A, Wadstrom T. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 2006; 7: 73–89
  • Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: 430S–436S
  • Salminen S. Human studies on probiotics: aspects of scientific documentation. Scand J Nutr 2001; 45: 8–12
  • Charteris WP, Kelly PM, Morelli L, Collins JK. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 1998; 84: 759–68
  • Ross RP, Desmond C, Fitzgerald GF, Stanton C. Overcoming the technological hurdles in the development of probiotic foods. J Appl Microbiol 2005; 98: 1410–17
  • Klaver FA, van der Meer R. The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol 1993; 59: 1120–4
  • Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998; 80: S209–212
  • Wang KY, Li SN, Liu CS, Perng DS, Su YC, Wu DC, et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 2004; 80: 737–41
  • Anderson JW, Gilliland SE. Effect of fermented milk (yoghurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr 1999; 18: 43–50
  • Cruchet S, Obregon MC, Salazar G, Diaz E, Gotteland M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003; 19: 716–21
  • Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J Antimicrob Chemother 2001; 47: 709–10
  • Koebnick C, Wagner I, Leitzmann P, Stern U, Zunft HJ. Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Can J Gastroenterol 2003; 17: 655–9
  • De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, et al. Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 2007; 292: G358–368
  • Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging 2003; 7: 75–7
  • Pereg D, Kimhi O, Tirosh A, Orr N, Kayouf R, Lishner M. The effect of fermented yogurt on the prevention of diarrhea in a healthy adult population. Am J Infect Control 2005; 33: 122–5
  • Tiollier E, Chennaoui M, Gomez-Merino D, Drogou C, Filaire E, Guezennec CY. Effect of a probiotics supplementation on respiratory infections and immune and hormonal parameters during intense military training. Mil Med 2007; 172: 1006–11
  • Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005; 16: 433–8
  • Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 1997; 4: 41–3
  • Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 2001; 138: 361–5
  • Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005; 16: 65–71
  • Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076–9
  • Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019–21
  • Di Caro S, Tao H, Grillo A, Franceschi F, Elia C, Zocco MA, et al. Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis. Eur J Gastroenterol Hepatol 2005; 17: 951–60
  • Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Tvede M, et al. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 2002; 21: 417–19
  • Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 2001; 20(2 Suppl)149–56
  • Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002; 74: 123–7
  • Linsalata M, Russo F, Berloco P, Caruso ML, Matteo GD, Cifone MG, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 2004; 9: 165–72
  • Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 2004; 70: 1176–81
  • Casas IA, Dobrogosz WJ. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microb Ecol Health Dis 2000; 12: 247–85
  • Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, Zilmer M. Antioxidative probiotic fermented goats’ milk decreases oxidative stress-mediated atherogenicity in human subjects. Br J Nutr 2003; 90: 449–56
  • Songisepp E, Kals J, Kullisaar T, Mandar R, Hutt P, Zilmer M, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J 2005; 4: 22
  • Kaur S, Kullisaar T, Mikelsaar M, Eisen M, Rehema A, Vihalemm T, et al. Successful management of mild atopic dermatitis in adults with probiotics and emollients. Cent Eur J Med 2008; 3: 215–20
  • Lencner, AA , Lencner, CP , Mikelsaar, ME , Tjuri, ME , Toom, MA , Valjaots, ME , , et al . [The quantitative composition of the intestinal lactoflora before and after space flights of different lengths.]. Nahrung 1984;28:607–13, (in German).
  • Lencner, A , Lencner, H , Brilis, V , Brilene, T , Mikelsaar, M , Turi, M . [The defense function of the digestive tract lactoflora.]. Nahrung 1987;31:405–11, (in German).
  • Mikelsaar MH, Annuk A, Shchepetova J, Mändar R, Sepp E, Björkstén B. Intestinal lactobacilli of Estonian and Swedish children. Microb Ecol Health Dis 2002; 14: 75–80
  • Kaizu H, Sasaki M, Nakajima H, Suzuki Y. Effect of antioxidative lactic acid bacteria on rats fed a diet deficient in vitamin E. J Dairy Sci 1993; 76: 2493–9
  • Parik T, Allikmets K, Teesalu R, Zilmer M. Oxidative stress and hyperinsulinaemia in essential hypertension: different facets of increased risk. J Hypertens 1996; 14: 407–10
  • Kaur S, Zilmer M, Eisen M, Kullisaar T, Rehema A, Vihalemm T. Patients with allergic and irritant contact dermatitis are characterized by striking change of iron and oxidized glutathione status in nonlesional area of the skin. J Invest Dermatol 2001; 116: 886–90
  • Karelson E, Bogdanovic N, Garlind A, Winblad B, Zilmer K, Kullisaar T, et al. The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense. Neurochem Res 2001; 26: 353–61
  • Mikelsaar M, Kullisaar T, Zilmer M. Antagonistic and antioxidative activity of lactobacilli and survival in oxidative milieu. Am J Clin Nutr 2001; 73: 495S–495S
  • Woodmansey EJ, McMurdo ME, Macfarlane GT, Macfarlane S. Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 2004; 70: 6113–22
  • Silvi S, Verdenelli MC, Orpianesi C, Cresci A. EU project Crownalife: functional foods, gut microflora and healthy ageing. Isolation and identification of lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Engin 2003; 56: 195–200
  • Pereira DI, Gibson GR. Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Appl Environ Microbiol 2002; 68: 4689–93
  • Vassos D, Maipa V, Voidarou C, Alexopoulos A, Bezirtzoglou E. Development of human lactic acid (LAB) gastrointestinal microbiota in a Greek rural population. Cent Eur J Biol 2008; 3: 55–60
  • Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol 2003; 10: 259–66
  • Vinderola CG, Medici M, Perdigon G. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J Appl Microbiol 2004; 96: 230–43
  • Midtvedt AC, Midtvedt T. Production of short chain fatty acids by the intestinal microflora during the first 2 years of human life. J Pediatr Gastroenterol Nutr 1992; 15: 395–403
  • Songisepp, E . Evaluation of technological and functional properties of the new probiotic Lactobacillus fermentum ME-3. Diss Med Univ Tartuensis, 2005.
  • Štšepetova J, Sepp E, Hütt P, Mikelsaar M. Estimation of lactobacilli, enterococci and bifidobacteria in faecal samples by quantitative bacteriology and FISH. Microecol Therapy 2002; 29: 51–9
  • Mikelsaar, M , Zilmer, M , Kullisaar, M , Annuk, H , Songisepp, E . Strain of microorganism Lactobacillus fermentum ME-3 as novel antimicrobial and antioxidative probiotic. Patent application no. P200100356 29.06.2001.
  • Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M. Characterization of intestinal lactobacilli as putative probiotic candidates. J Appl Microbiol 2003; 94: 403–12
  • Kandler, O, Weiss, N. Regular gram positive nonsporing rods. In: PHA Sneath, Mair, NS, Sharp, MS, Holt, JG, Bergey's manual of systematic bacteriology, vol 2. Baltimore: Williams & Wilkins, 1986;208–34.
  • Smidt, I , Stsepetova, J , Hütt, P , Sepp, E , Mikelsaar, M . Evaluation of biogenic amines in urine after synbiotic consumption. Probiotics, Synbiotics and Functional Foods: Scientific and Clinical Aspects, 15–16 May 2007, Peterburg, Russia: Medline-Medina, 2007;1-2:A13-A14.
  • Songisepp, E , Mikelsaar, M , Rätsep, M , Zilmer, M , Hütt, P , Utt, M , , et al . Isolated microorganism strain Lactobacillus plantarum Tensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for production of antihypertensive medicine and method for suppressing non-starter lactobacilli in food product. Estonian Patent Office. 13.05.2008. P200800026.
  • Bover-Cid S, Holzapfel WH. Improved screening procedure for biogenic amine production by lactic acid bacteria. Int J Food Microbiol 1999; 53: 33–41
  • Kidata M, Igarashi K, Hirose S, Kitagawa H. Inhibition by polyamines of lipid peroxide formation in rat liver microsomes. Biochem Biophys Res Commun 1979; 87: 388–94
  • Fernandez MF, Boris S, Barbes C. Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 2003; 94: 449–55
  • Alander M, Satokari R, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol 1999; 65: 351–4
  • Cesana BM. Comments on ‘Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study’ by Florakis et al.(2000). Clin Endocrinol 2001; 55: 695–7
  • Liener IE, Sharon N, Goldstein IJ. The lectins. Properties, functions, and applications in biology and medicine. Academic Press, Orlando, FL 1986
  • Onyshchenko, AM , Korobkova, KS , Kovalenko, NK , Kasumova, SO , Skrypal, IH . [The role of the carbohydrate composition of the glycocalyx in some species of lactobacilli in the manifestation of their adhesive properties.]. Mikrobiol Z 1999;61:22–8, (in Ukrainian).
  • Annuk H, Hynes SO, Hirmo S, Mikelsaar M, Wadstrom T. Characterisation and differentiation of lactobacilli by lectin typing. J Med Microbiol 2001; 50: 1069–74
  • Kärkkainen UM, Ikaheimo R, Katila ML, Siitonen A. Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis 2000; 32: 495–9
  • Ouwehand AC, Derrien M, de Vos W, Tiihonen K, Rautonen N. Prebiotics and other microbial substrates for gut functionality. Curr Opin Biotechnol 2005; 16: 212–17
  • Annuk H, Hirmo S, Turi E, Mikelsaar M, Arak E, Wadstrom T. Effect on cell surface hydrophobicity and susceptibility of Helicobacter pylori to medicinal plant extracts. FEMS Microbiol Lett 1999; 172: 41–5
  • Songisepp E, Kullisaar T, Hutt P, Elias P, Brilene T, Zilmer M, et al. A new probiotic cheese with antioxidative and antimicrobial activity. J Dairy Sci 2004; 87: 2017–23
  • Annuk, H . Selection of medicinal plants and intestinal lactobacilli as antimicrobial components for functional foods. Diss Med Univ Tartuensis, Tartu, 2002.
  • Hütt P, Shchepetova J, Lõivukene K, Kullisaar T, Mikelsaar M. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens. J Appl Microbiol 2006; 100: 1324–32
  • Hütt, P , Lõivukene, K , Utt, M . Antagonistic activity of probiotic Lactobacillus fermentum ME-3 against H. pylori strains. 6th International Workshop on Pathogenesis and Host Response in Helicobacter Infections, 23–26. June, 2004, Helsingör, Denmark.
  • Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?. Aliment Pharmacol Ther 2006; 23: 1077–86
  • Marchand J, Vandenplas Y. Micro-organisms administered in the benefit of the host: myths and facts. Eur J Gastroenterol Hepatol 2000; 12: 1077–88
  • Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, et al. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis 2006; 42: 35–44
  • Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I, Romond MB, et al. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends Food Sci Technol 2008; 19: 102–14
  • Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford University Press, New York 1999
  • Sies, H . Oxidative stress: oxidants and antioxidants. London, Academic Press, 1991.
  • Stocker R, Keaney JF, Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381–478
  • Kals J, Kampus P, Kals M, Zilmer K, Kullisaar T, Teesalu R, et al. Impact of oxidative stress on arterial elasticity in patients with atherosclerosis. Am J Hypertens 2006; 19: 902–8
  • Stojiljkovic V, Todorovic A, Radlovic N, Pejic S, Mladenovic M, Kasapovic J, et al. Antioxidant enzymes, glutathione and lipid peroxidation in peripheral blood of children affected by coeliac disease. Ann Clin Biochem 2007; 44(Pt 6)537–43
  • Krzystek-Korpacka M, Neubauer K, Berdowska I, Boehm D, Zielinski B, Petryszyn P, et al. Enhanced formation of advanced oxidation protein products in IBD. Inflamm Bowel Dis 2008; 14: 794–802
  • Tsukahara H. Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr Med Chem 2007; 14: 339–51
  • Suzuki M, Kamei M, Itabe H, Yoneda K, Bando H, Kume N, et al. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis 2007; 13: 772–8
  • Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA. Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol 2008; 67: 523–31
  • Vincent HK, Innes KE, Vincent KR. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9: 813–39
  • Mensink RP, Aro A, Den Hond E, German JB, Griffin BA, ten Meer HU, et al. PASSCLAIM – Diet-related cardiovascular disease. Eur J Nutr 2003; 42(Suppl 1)I6–27
  • Vaughan EE, Heilig HG, Ben-Amor K, de Vos WM. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev 2005; 29: 477–90
  • Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, et al. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 2002; 72: 215–24
  • Mikelsaar M, Zilmer M. Probiotics series (4) Probiotics biotherapeutics & health: microbial, biochemical and probiotical history (ME-3), C Schiavi. Mofin Alce, NovaraItaly 2005; 114–37
  • Kullisaar, T , Songisepp, E , Aunapuu, M , Kilk, K , Arend, A , Mikelsaar, M , , et al . Complete glutathione system in probiotic L. fermentum ME-3. Appl Biochem Microbiol 2009; 45, (in press).
  • Jarvenpaa S, Tahvonen RL, Ouwehand AC, Sandell M, Jarvenpaa E, Salminen S. A probiotic, Lactobacillus fermentum ME-3, has antioxidative capacity in soft cheese spreads with different fats. J Dairy Sci 2007; 90: 3171–7
  • Teemu H, Seppo S, Jussi M, Raija T, Kalle L. Reversible surface binding of cadmium and lead by lactic acid and bifidobacteria. Int J Food Microbiol 2008; 125: 170–5
  • Truusalu K, Naaber P, Kullisaar T, Tamm H, Mikelsaar R-H, Zilmer K, et al. The influence of antibacterial and antioxidative probiotic lactobacilli on gut mucosa in mouse model of Salmonella infection. Microb Ecol Health Dis 2004; 16: 180–7
  • Kullisaar, T , Mikelsaar, M , Kaur, S , Songisepp, E , Zilmer, K , Hütt, P , . Probiotics, oxidative stress and diseases. In: D Ćurić, et al. Proceedings of the 2008 Joint Central European Congress: 4th Central European Congress on Food and 6th Croatian Congress of Food Technologists, Biotechnologists and Nutritionists, 15–17 May 2008, Cavtat, Croatia, 2008;1:367–73. ISBN 978-953-6207-87-9.
  • Kullisaar, T , Zilmer, K , Vihalemm, T , Zilmer, M . Consumption of antioxidative probiotic probiotic L. fermentum ME-3 and its impact on post-prandial lipid profile in human volunteers. Third Central European Congress on Food, May 2006, Sofia, Bulgaria: p. 208.
  • Truusalu K, Mikelsaar RH, Naaber P, Karki T, Kullisaar T, Zilmer M, et al. Eradication of Salmonella Typhimurium infection in a murine model of typhoid fever with the combination of probiotic Lactobacillus fermentum ME-3 and ofloxacin. BMC Microbiol 2008; 8: 132
  • Igarashi T, Kono Y, Tanaka K. Molecular cloning of manganese catalase from Lactobacillus plantarum. J Biol Chem 1996; 271: 29521–4
  • Rochat T, Gratadoux JJ, Gruss A, Corthier G, Maguin E, Langella P, et al. Production of a heterologous nonheme catalase by Lactobacillus casei: an efficient tool for removal of H2O2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Appl Environ Microbiol 2006; 72: 5143–9
  • Mikelsaar M, Hütt P, Kullisaar T, Zilmer K, Zilmer M. Double benefit claims for antimicrobial and antioxidative probiotic. MEHD 2008; 20(4)184–88
  • Mattila-Sandholm T, Blum S, Collins JK, Crittenden R, de Vos W, Dunne C, et al. Probiotics: towards demonstrating efficacy. Trends Food Sci Technol 1999; 10: 393–9
  • Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001; 152: 735–41
  • Saulnier DMA, Hutt P, Mikelsaar M, Bosscher D, Gibson G, Kolida S. Effects of a symbiotic on biomarkers of oxidative stress and fecal microbiota in healthy adults: results of a cross-over double-blind placebo controlled trial. Proc Nutr Soc 2007; 66: 101A
  • Mikelsaar, M , Zilmer, M , Kullisaar, T , Annuk, H , Songisepp, E . Strain of microorganism Lactobacillus fermentum ME-3 as novel antimicrobial and antioxidative probiotic. United States Patent 7, 244, 424 B2. Approved July 17, 2007.
  • Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006; 8: 1865–79
  • Karelson E, Mahlapuu R, Zilmer M, Soomets U, Bogdanovic N, Langel U. Possible signaling by glutathione and its novel analogue through potent stimulation of fontocortical G proteins in normal aging and in Alzheimer's disease. Ann N Y Acad Sci 2002; 973: 537–40
  • Zilmer M, Soomets U, Rehma A, Langel Ü. Drug Design Reviews – Online 2005; 2: 121–7
  • Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailon E, Nieto A, et al. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 2007; 97: 96–103
  • de la Asuncion JG, Millan A, Pla R, Bruseghini L, Esteras A, Pallardo FV, et al. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 1996; 10: 333–8
  • Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114: 2850–70
  • Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR, Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008; 299: 2287–93
  • Kampus P, Kals J, Ristimae T, Muda P, Ulst K, Zilmer K, et al. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens 2007; 25: 819–25
  • George J. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 2008; 5: 531–40
  • Lopez-Miranda J, Perez-Martinez P, Marin C, Moreno JA, Gomez P, Perez-Jimenez F. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr Opin Lipidol 2006; 17: 132–8
  • Marsillach J, Camps J, Ferré N, Beltran R, Rull A, Mackness B, et al. Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol 2009; 9: 3–10
  • Elliott WJ. Renovascular hypertension: an update. J Clin Hypertens (Greenwich) 2008; 10: 522–33
  • Bhatt DL. Anti-inflammatory agents and antioxidants as a possible “third great wave” in cardiovascular secondary prevention. Am J Cardiol 2008; 101(10A)4D–13